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In previous studies using mice with macrophage-specific loss of TRPC3 we found a significant, selective 
effect of TRPC3 on the biology of M1, or inflammatory macrophages. Whereas activation of some 
components of the unfolded protein response and the pro-apoptotic mediators CamkII and Stat1 
was impaired in Trpc3-deficient M1 cells, gathering insight about other molecular signatures within 
macrophages that might be affected by Trpc3 expression requires an alternative approach. In the 
present study we conducted RNA-seq analysis to interrogate the transcriptome of M1 macrophages 
derived from mice with macrophage-specific loss of TRPC3 and their littermate controls. We identified 
160 significantly differentially expressed genes between the two groups, of which 62 were upregulated 
and 98 downregulated in control vs. Trpc3-deficient M1 macrophages. Gene ontology analysis 
revealed enrichment in processes associated to cellular movement and lipid signaling, whereas the 
enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways included networks for calcium 
signaling and cell adhesion molecules, among others. This is the first deep transcriptomic analysis of 
macrophages in the context of Trpc3 deficiency and the data presented constitutes a unique resource to 
further explore functions of TRPC3 in macrophage biology.
Transient Receptor Potential Canonical 3 (TRPC3) is a non-selective Ca2+-permeable channel that belongs to 
the TRPC family (TRPC1-7) within the larger TRP superfamily of cation channels1,2. Under physiological con-
ditions TRPC3 is regulated by receptor stimulation of diacylglycerol-producing phospholipases and exhibits 
receptor-independent or constitutive function3. In previous studies from our laboratory using a bone marrow 
transplantation strategy as a first approach to examine a potential role of the macrophage Trpc3 in atheroscle-
rosis, we found that the advanced aortic plaques of hyperlipidemic mice with bone marrow-selective deletion 
of Trpc3 have less necrosis and reduced number of apoptotic macrophages than control animals, parameters 
usually indicative of more stable plaques4. In more recent studies using macrophages derived from mice with 
macrophage-specific loss of TRPC3 function and differentiated in vitro to the M1 and M2 types, we observed that 
lack of Trpc3 reduces activation of the unfolded protein response (UPR) with a consequent decreased suscepti-
bility to endoplasmic reticulum (ER) stress-induced apoptosis, providing a potential explanation to the in vivo 
findings5. Remarkably, this effect was selective for M1 macrophages, as genetic or pharmacological inhibition of 
Trpc3 reduced activation of the UPR and ER stress-induced apoptosis in M1, but not M2 macrophages5. In that 
study, we also showed that the lack of Trpc3 impaired the functions of calmodulin-dependent protein kinase II 
and Stat1 only in M1 macrophages. Considering that TRPC3 is a calcium-permeable channel, evaluating the 
impact of TRPC3 expression on signaling molecules, whose performance depends, directly or indirectly, upon 
calcium influx into the cell seemed a logical approach. However, gathering insight on molecular signatures within 
macrophages that might be specifically affected by TRPC3 requires an alternative tactic. In this context, an unbi-
ased genome-wide approach provides a more powerful strategy6. In the present study we conducted RNA-seq 
analysis to interrogate the whole transcriptome of M1 macrophages derived from mice with macrophage-specific 
loss of Trpc3 function or their littermate controls. The data obtained is of specific value and provides information 
on global signatures to understand the contributions of coding and non-coding RNAs that may exert an effect in 
shaping the macrophage transcriptome pathways, and on potential molecular players whose expression/function 
is affected by Trpc3.
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Results
To obtain unbiased insight on molecular signatures within M1 macrophages that might be specifically affected by 
the loss of Trpc3 expression, we performed deep RNA sequencing (RNA-seq) analysis of RNA samples of M1 mac-
rophages derived from bone marrows of mice with macrophage-specific loss of Trpc3 function (MacTRPC3KO, 
or Trpc3-deficient cells) or their littermate controls (TRPC3lox/lox, controls or TRPC3-expressing cells). Following 
in vitro interferon γ -induced differentiation of bone marrow-derived macrophages to the M1 type (as we 
described in4,5,7), RNA was isolated and subjected to RNA-seq analysis. The average paired-end sequencing reads 
per individual library was 110.2 million, with 97% of read alignment. RNA-sequencing detected 14,605 and 
14,867 transcripts in TRPC3lox/lox and MacTRPC3KO M1 macrophages, respectively. This comprised transcripts 
for both protein-coding genes and non-coding RNAs. After gene expression quantification with DESeq normali-
zation, an unpaired t-test was carried out to compare sequence reads derived from control (n = 3) vs. Trpc3 defi-
cient (n = 3) M1 macrophages. This comparison identified 160 significantly differentially expressed genes (fold 
change ≥ 2.0, p < 0.05) between the two groups (Tables S2 and S3). Among these, 62 transcripts were upregulated 
in control vs. MacTRPC3KO M1 macrophages (range + 2.0 to 10.54 fold; Fig. 1A), whereas 98 transcripts were 
downregulated in controls compared to the TRPC3-deficient M1 cells (range − 2.0–17.1 fold; Fig. 1B).
We next selected the top ten transcripts with highest fold change in expression (upregulated or downregu-
lated) between Trpc3-expressing and Trpc3-deficient M1 macrophages for further validation by qRT-PCR (up- 
and down-regulated genes, Tables S4 and S5). Among these, the expression of Chi31l, Ccdc122, Hddc3, Exd1 and 
Ly6c2 were significantly elevated in control macrophages compared to Trpc3-deficient M1 cells (Fig. 2A), whereas 
Igf2bp3, Cyp26b1, Rcan2, Nxpe5, Alpl and Camk2b were confirmed as significantly downregulated in controls 
compared to Trpc3-deficient M1 cells (Fig. 2B). We also examined the expression level of 7 long non-coding 
RNAs (LincRNA, fold change ≥ 2.0; Tables S2 and S3). The results from qRT-PCR analysis showed that LincRNAs 
AC020971.1 and Gm14168 were downregulated in TRPC3-deficient M1 macrophages compared to controls 
(Fig. 3). In addition, 195 novel genes –i.e., new gene annotations with no knowledge of whether they are coding 
or non-coding RNAs- (Table S6) were detected in samples from both control and Trpc3-deficient M1 cells, as well 
as 21 differentially spliced transcripts between Trpc3-expressing and Trpc3-deficient M1 macrophages (Table S7).
We next conducted a web based gene ontology (GO) analysis to identify the biological processes that were 
significantly enriched based on those transcripts that were significantly differentially expressed between control 
and MacTRPC3KO M1 macrophages. The top ten GO enriched biological processes are listed in Table S8. A 
majority of processes were associated to cellular movement (cell migration, motility, locomotion, movement) 
and lipid signaling (PI3-kinase and lipid kinase activities, inositol lipid and phosphinositol signaling), all with ≥ 
2.0 fold change (p < 0.05). In addition, Table S9 shows the enriched Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathways associated with transcripts that exhibited significantly reduced expression in control M1 mac-
rophages compared to the TRPC3-deficient cells. These included, among others, calcium signaling, cell and focal 
Figure 1. Heat map of differentially expressed transcripts ordered alphabetically. Transcripts with 
statistically significant alterations (p < 0.05) in expression between control (TRPC3-expressing, n = 3) and 
MacTRPC3KO (TRPC3-deficient, n = 3) M1 macrophages. A: genes upregulated in control vs. MacTRPC3KO; 
B: genes downregulated in control vs. MacTRPC3KO. Intensities are normalized for each differentially 
expressed (2.0-fold up/down; p < 0.05) from RNA sequencing data. Each column represents 1 of 3 RNA 
samples, i.e., biological replicates for each genotype.
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adhesion molecules and actin cytoskeleton. Amongst the enriched KEGG pathways associated to transcripts with 
significant upregulation in control M1 macrophages compared to TRPC3-deficient cells, were those for salivary 
secretion, cytokine-cytokine receptor interaction, endocytosis, phagosome and metabolic pathways (Table S10).
Since pathway analysis identified a number of processes associated to cell motility that were upregulated in 
Trpc3-deficient M1 macrophages, we next wished to examine whether Trpc3 deficiency had indeed an impact 
on the ability of macrophages to migrate in response to a chemokine. The data in Fig. 4 shows that M1 mac-
rophages with loss of TRPC3 function exhibit increased migration in response to CCL2 compared to Trpc3 
Figure 2. Validation analysis of select RNAseq data with qRT-PCR. The top 10 genes that exhibited highest 
fold change in differential expression between control and MacTRPC3KO M1 macrophages (Tables S4 and S5) 
were evaluated by qRT-PCR as described in Methods. A) qRT-PCR of the top 10 genes with highest fold change 
in upregulated expression in control vs. MacTRPC3KO macrophages. B) qRT-PCR of the top 8 genes with 
highest fold change in downregulated expression in control vs. MacTRPC3KO macrophages. C77080 and 
Apobec3 (Table S3) produced inconsistent results and are not included in the figure. Data were normalized 
to Gapdh expression and fold-change in expression was calculated by the 2−ΔΔCT method. *p < 0.05; ns: not 
statistically significant.
Figure 3. qRT-PCR analysis of lincRNAs AC020971.1 and Gm14168 which were prominently differentially 
expressed in control vs. MacTRPC3KO M1 macrophages (Tables S2 and S3). Data was normalized to Gapdh 
expression and fold-change in expression was calculated by the 2−ΔΔCT method. *p < 0.05; ns: not statistically 
significant.
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expressing M1 cells. As expected, CCL2-induced migration of M1 macrophages was almost completely prevented 
by pre-treatment with the retention cue netrin-1, regardless of Trpc3 expression.
Discussion
Previous work from our group demonstrated that in macrophages the TRPC3 channel has a pro-apoptotic role, 
as evidenced by reduced necrosis and number of apoptotic macrophages in the advanced atherosclerotic plaques 
of a hyperlipidemic mouse model of atherosclerosis with bone marrow-selective deletion of Trpc34. Additional 
in vitro studies in polarized macrophages derived from mice with macrophage-specific loss of TRPC3 function 
showed that the effects of TRPC3 were selective for the M1, or inflammatory macrophages, with no impact on 
the M2, or anti-inflammatory type5. A priori, identifying global alterations in signaling candidates downstream 
of Trpc3 that might be affected by the loss of channel function is not feasible from a canonical biochemical/cell 
biology stand point, considering the myriad of cellular processes that may be affected, directly or indirectly, by 
Trpc3. Thus, gathering insight on molecular signatures within macrophages that might be specifically affected 
by the lack of Trpc3 requires a different strategy. The deep transcriptome profiling performed in this study was 
aimed at obtaining detailed, unbiased information on global transcriptomic signatures in Trpc3 deficient M1 
macrophages. Aside from generating a genome-wide transcriptome blueprint as a result of lack of Trpc3, the 
goal was also to uncover previously unknown and thereby underappreciated contributions of non-coding RNAs 
in shaping transcriptome pathways in inflammatory M1 macrophages. Applying a stringent detection threshold 
(> 2.0-fold change) and a cut-off p-value of < 0.05, we identified statistically significant changes in the expres-
sion levels of 160 genes between Trpc3-expressing and Trpc3-deficient M1 macrophages. This revealed the 
existence of differentially expressed transcripts for protein-coding RNAs, non-coding RNAs and new genes in 
M1 macrophages with loss of TRPC3 function, when compared to control cells. Among the non-coding RNAs, 
RNA-seq analysis revealed 7 long non-coding RNAs (lincRNAs) with differential expression between control 
and Trpc3-deficient M1 macrophages. Two out of this 7 lincRNAs, lincRNAs AC020971.1 and Gm14168 were 
prominently downregulated in macrophages with loss of Trpc3 function compared to Trpc3-expressing cells. 
LincRNA AC020971.1 has been reported to be upregulated in epithelial cells from mouse lenses8, and Gm14168 
is a predicted annotation with little experimental validation. The targets and cellular functions of both of these 
LincRNAs remain unknown.
To gain insight into potential biological processes and molecular pathways affected by loss of Trpc3 in M1 
macrophages, we evaluated the differentially expressed genes by using both gene ontology (GO) and KEGG. The 
GO analysis showed enrichment in several biological processes associated to cellular movement and lipid signal-
ing. Although our previous studies focused on effects of TRPC3 in macrophage apoptosis, the changes that were 
revealed here in these other pathways are likely to contribute to other phenotypic features of M1 macrophages with 
loss of Trpc3 function. The changes observed in expression levels of several genes associated with cell movement 
and locomotion suggest the existence of alterations in motility pathways in TRPC3-deficient M1 macrophages. 
This contention is supported by functional data from an in vitro migration assay showing that Trpc3-deficient 
M1 macrophages have increased migratory response to CCL2. This is of interest, as migration and motility are 
critical functions of macrophages in the setting of atherosclerosis9–11. Changes in genes associated to cell migra-
tion have also been observed in other models of altered TRPC3 expression. For example, increased migration has 
been associated to augmented expression of TRPC3 in monocytes derived from patients with essential hyper-
tension12. A recent microarray-based transcriptomic analysis of mouse Purkinje cells carrying the Moonwalker 
gain-of-function point mutation in Trpc3 revealed several biological pathways and functions that were sig-
nificantly enriched in gene categories including lipid metabolism and cellular assembly and organization13. 
Worth noting among those genes showing upregulated expression in Trpc3-deficient M1 macrophages, are 
Rcan2 and Camk2b. Rcan2 (regulator of calcineurin) is a calcineurin-interacting protein that inhibits the phos-
phatase activity of calcineurin in several cell types14. M1 macrophages with loss of Trpc3 show increased levels 
Figure 4. M1 macrophages prepared from MacTRPC3KO or littermate control mice (control) were 
suspended in complete medium and added (106/ml) to the upper compartment of 96-well Boyden 
chambers (5 μm pore), in the presence or absence of CCL2 (80 ng/ml) in the lower compartment, and 
with or without pre-treatment with mouse recombinant netrin-1 (40 min, 200 ng/ml). After 12 h, cells that 
migrated to the lower compartment were counted (5 random fields/well, triplicate wells/condition). Shown is 
fold change over controls (# migrating cells in condition “x”/# migrating cells in control).
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of phospho-AKT, a key survival molecule in these cells (Solanki and Vazquez, unpublished observations), and 
calcineurin-mediated dephosphorylation of Akt is a widespread negative regulatory mechanism of this survival 
pathway15. Thus, the findings from the transcriptomic analysis point to Rcan2 upregulation in Trpc3-deficient 
M1 macrophages as a potential mechanism underlying the decreased susceptibility of these cells to apoptosis5. 
In M1 macrophages TRPC3 function is coupled to tonic activity of CAMKII, and genetic or pharmacological 
inhibition of Trpc3 indeed impairs activation of this kinase5. In this context, it is likely that the marked upregula-
tion of Camk2b in TRPC3-deficient macrophages may represent an attempt to compensate for such uncoupling. 
Among those transcripts with prominent downregulated expression in Trpc3-deficient M1 macrophages, it is 
worth noting that both Chi2l1 and Ly6C2, which code for chitinase 3-like 1 and lymphocyte antigen 6 complex 
locus C2, respectively, are associated to a variety of inflammatory processes in both infectious and non-infectious 
diseases16,17. It remains to be determined whether downregulation of these genes has any effect on the inflamma-
tory phenotype of M1 macrophages with Trpc3 deficiency4,5.
In sum, the present studies represent the first transcriptomic analysis of macrophages with loss of TRPC3 and 
identify alterations in a number of molecular pathways, many of which have not been previously linked to Trpc3. 
This information thus represents a unique resource for future studies aimed at identifying novel functions of 
Trpc3 in the context of macrophage biology, and to reveal whether alterations in these pathways could be targeted 
to modulate diseases with prominent macrophage involvement.
Methods
Experimental animals. All animal studies described in this work conform to the Guide for Care and Use 
of Laboratory Animals published by the NIH and have been approved by the University of Toledo Institutional 
Animal Care and Use Committee. Generation and characterization of LysMCre +/−/Trpc3lox/lox mice (for simplic-
ity, MacTRPC3KO) was described in detail in5.
Preparation of bone marrow-derived macrophages. Culture of bone marrow-derived macrophages, in 
vitro differentiation to the M1 type and phenotypic marker profiling of M1 cells was performed as we described in4,5,7,18. 
Importantly, Trpc3 deletion does not affect either macrophage maturation or their differentiation to the M1 type4,5.
RNA library construction, sequencing and data analysis. Total RNA was extracted using 5 
PRIME PerfectPure™ Purification System (5prime) before dispatch to Expression Analysis (EA) Sequencing 
& Bioinformatics (Durham, NC; www.ExpressionAnalysis.com). RNA quality was assessed by electrophoresis 
and bioanalyzer prior to RNA sequencing (Supplemental Fig. 1). An input of 100 ng of total RNA was used to 
construct cDNA libraries (TruSeq Stranded mRNA Sample Prep Kit, Illumina, #RS-122-2103) following the man-
ufacturer’s instructions. Deep sequencing was done using the Illumina High Seq 2500 platform.
For RNA-seq analysis, low quality reads were removed and the adapter sequences were trimmed. The result-
ing sequences were mapped to the mouse reference genome (MM10, Ensemble genes and transcripts) using the 
Strand NGS software (Strand Life Sciences, version 2.1) following RNA alignment and RNA-seq analysis pipeline 
with standard parameters. Only those reads with high quality scores were retained for further analysis. Sequences 
aligned with individual transcripts were counted digitally. Differential gene expression was carried out with 
DESeq v.3.0 normalization to facilitate the comparison of transcripts among samples with fold change > 2.0 and 
applying the Benjamini-Hochberg multiple test correction at a false discovery rate of 5% (adjusted p value < 0.05). 
Gene annotations were provided by NCBI Entrez Gene database. Enrichment analysis of genes that were over- or 
under-represented was performed by Gene Ontology (GO) analysis19. Further analysis of biological pathways and 
molecular networks was conducted with the Kyoto Encyclopedia of Genes and Genomes (KEGG)20,21.
Reverse transcription and real-time PCR. Total RNA was extracted using 5 PRIME PerfectPure™ 
Purification System (5prime). RNA samples were quantitatively analyzed using a NanoDrop ND-1000 to 
check the purity and concentration of the samples. One μ g of total RNA was converted to cDNA using the 
superscript-III first strand synthesis kit (Invitrogen). The ABI 7300 Real Time PCR System with Power SYBR 
Green PCR Master Mix (Life Technologies) was used to carry out quantitative reverse transcription polymerase 
chain reaction (qRT-PCR) in duplicates. Gene expression levels were normalized with Gapdh, and the changes in 
expression were calculated by the 2−ΔΔCT method as in22. Primer sequences are provided in Table S1.
In vitro migration assay. this was performed essentially as described in23. M1 macrophages derived from bone 
marrows of MacTRPC3KO mice or their littermate controls were suspended in complete medium and added (106/ml) 
to the upper compartment of 96-well Boyden chambers (5 μ m pore). The lower compartment of the chambers con-
tained the chemoattractant CCL2 (80 ng/ml). Alternatively, M1 macrophages were incubated with mouse recombi-
nant netrin-1 (40 min, 200 ng/ml) before being added to the wells. The migration proceeded for 12 h, and at the end of 
this period migrated cells were counted (5 random fields/well, each condition run in triplicate). Results were expressed 
as fold change over controls (number of migrating cells in condition “x”/number of migrating cells in control).
Statistical analysis. Statistical differences were determined using the Student’s t-Test and statistical signifi-
cance was set at p < 0.05. Data are expressed as mean ± SEM.
References
1. Smedlund, K., Bah, M. & Vazquez, G. On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular 
disease. Cardiovasc Hematol Agents Med Chem 10, 265–274 (2012).
2. Liao, Y., Abramowitz, J. & Birnbaumer, L. The TRPC family of TRP channels: roles inferred (mostly) from knockout mice and 
relationship to ORAI proteins. Handb Exp Pharmacol 223, 1055–1075, doi: 10.1007/978-3-319-05161-1_14 (2014).
3. Vazquez, G., Tano, J. Y. & Smedlund, K. On the potential role of source and species of diacylglycerol in phospholipase-dependent 
regulation of TRPC3 channels. Channels (Austin, Tex.) 4, 232–240. (2010).
www.nature.com/scientificreports/
6Scientific RepoRts | 7:39867 | DOI: 10.1038/srep39867
4. Tano, J. Y. et al. Bone marrow deficiency of TRPC3 channel reduces early lesion burden and necrotic core of advanced plaques in a 
mouse model of atherosclerosis. Cardiovasc Res 101, 138–144, doi: 10.1093/cvr/cvt231 (2014).
5. Solanki, S., Dube, P. R., Tano, J. Y., Birnbaumer, L. & Vazquez, G. Reduced endoplasmic reticulum stress-induced apoptosis and 
impaired unfolded protein response in TRPC3-deficient M1 macrophages. Am J Physiol Cell Physiol 307, C521–531, doi: 10.1152/
ajpcell.00369.2013 (2014).
6. Gopalakrishnan, K., Kumarasamy, S., Mell, B. & Joe, B. Genome-wide identification of long noncoding RNAs in rat models of 
cardiovascular and renal disease. Hypertension 65, 200–210, doi: 10.1161/hypertensionaha.114.04498 (2015).
7. Lee, R. H. & Vazquez, G. Evidence for a prosurvival role of alpha-7 nicotinic acetylcholine receptor in alternatively (M2)-activated 
macrophages. Physiol Rep 1, e00189, doi: 10.1002/phy2.189 (2013).
8. Hoang, T. V. et al. Comparative transcriptome analysis of epithelial and fiber cells in newborn mouse lenses with RNA sequencing. 
Molecular vision 20, 1491–1517 (2014).
9. Ramkhelawon, B. et al. Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and 
survival. Arteriosclerosis, thrombosis, and vascular biology 33, 1180–1188, doi: 10.1161/atvbaha.112.301008 (2013).
10. van Gils, J. M. et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages 
from plaques. Nat Immunol 13, 136–143, doi: 10.1038/ni.2205 (2012).
11. Wanschel, A. et al. Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage 
retention. Arteriosclerosis, thrombosis, and vascular biology 33, 886–893, doi: 10.1161/atvbaha.112.300941 (2013).
12. Zhao, Z. et al. Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential 
channel canonical type 3 channels. PloS one 7, e32628, doi: 10.1371/journal.pone.0032628 (2012).
13. Dulneva, A. et al. The mutant Moonwalker TRPC3 channel links calcium signaling to lipid metabolism in the developing 
cerebellum. Human molecular genetics 24, 4114–4125, doi: 10.1093/hmg/ddv150 (2015).
14. Li, W., Bell, H. W., Ahnn, J. & Lee, S. K. Regulator of Calcineurin (RCAN-1) Regulates Thermotaxis Behavior in Caenorhabditis 
elegans. Journal of molecular biology 427, 3457–3468, doi: 10.1016/j.jmb.2015.07.017 (2015).
15. Park, C. H. et al. Calcineurin mediates AKT dephosphorylation in the ischemic rat retina. Brain research 1234, 148–157, 
doi: 10.1016/j.brainres.2008.07.082 (2008).
16. Di Rosa, M. & Malaguarnera, L. Chitinase 3 Like-1: An Emerging Molecule Involved in Diabetes and Diabetic Complications. 
Pathobiology : journal of immunopathology, molecular and cellular biology 83, 228–242, doi: 10.1159/000444855 (2016).
17. Ramachandran, P. et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the 
regression of murine liver fibrosis. Proceedings of the National Academy of Sciences of the United States of America 109, E3186–3195, 
doi: 10.1073/pnas.1119964109 (2012).
18. Tano, J. Y. et al. Impairment of survival signaling and efferocytosis in TRPC3-deficient macrophages. Biochem Biophys Res Commun 
410, 643–647, doi: 10.1016/j.bbrc.2011.06.045 (2011).
19. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics 25, 25–29, 
doi: 10.1038/75556 (2000).
20. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. 
Nucleic acids research 44, D457–462, doi: 10.1093/nar/gkv1070 (2016).
21. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 28, 27–30 (2000).
22. Saad, Y. et al. Fine-mapping and comprehensive transcript analysis reveals nonsynonymous variants within a novel 1.17 Mb blood 
pressure QTL region on rat chromosome 10. Genomics 89, 343–353, doi: 10.1016/j.ygeno.2006.12.005 (2007).
23. Ly, N. P. et al. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proceedings of the National Academy of Sciences of the United 
States of America 102, 14729–14734, doi: 10.1073/pnas.0506233102 (2005).
Acknowledgements
This work was supported by NIH grant R01HL111877-04 to G.V., HL-076709, HL-112641 and HL-020176 to B.J., 
and by the Intramural Research Program of the NIH (project Z01-ES101684 to L.B.).
Author Contributions
S.K.: data analysis and interpretation, manuscript preparation; S.S.: execution of experiments; O.A.: data analysis; 
B.J.: experimental design, data analysis and interpretation, manuscript preparation; L.B.: data analysis and 
interpretation, manuscript preparation; G.V.: experimental design, data analysis and interpretation, manuscript 
preparation. All authors reviewed the manuscript.
Additional Information
Accession codes: The RNA-seq data presented in this manuscript has been deposited in the NCBI GEO 
database (GSE8478).
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Kumarasamy, S. et al. Deep Transcriptomic Profiling of M1 Macrophages Lacking 
Trpc3. Sci. Rep. 7, 39867; doi: 10.1038/srep39867 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons 
license, users will need to obtain permission from the license holder to reproduce the material. To view a copy 
of this license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
